Τόμος 15 (2001) – Τεύχος 2 – Άρθρο 1 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 15 (2001) – Issue 2 – Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Sodium-hydrogen exchanger (NHE) inhibition: a new therapeutic approach for ischemic heart disease
Authors C.E. Papadopoulos, H.I. Karvounis and G.E. Louridas

1st  Department of Cardiology, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, GREECE

Citation Papadopoulos, C.E., Karvounis, H.I.., Louridas, G.E.: Sodium-hydrogen exchanger (NHE) inhibition: a new therapeutic approach for ischemic heart disease, Epitheorese Klin. Farmakol. Farmakokinet. 15(2): 61-68 (2001)
Publication Date Received for publication: 2 March 2001

Accepted for publication: 20 March 2001

Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords Sodium-hydrogen exchanger, myocardial cell, ischemia, metabolism, sodium-hydrogen exchanger inhibitors, cardioprotection.
Other Terms review article
Summary Sodium-Hydrogen Exchanger (NHE), an antiporter system exchanging sodium and hydrogen ions across cell membrane in the majority of eukaryotic cells, plays a pivotal role in the regulation of intracellular pH and thus protect the cell from stimuli producing acidification and evolving death. This article, reviews all the up to date data, concerning this novel cell pump. It takes into consideration its structural features, summarizes the regulation and the effect of this antiport on intracellular ions metabolism and its effect on intracellular pH regulation and cell metabolism. It also describes a new class of drugs, the so called sodium hydrogen exchanger inhibitors, which seem to exert considerable cardioprotective effects, by inhibiting NHE function thus reducing detrimental calcium overload (amiloride and cariporide being the most important and excessively studied representatives). It is finally seeking into clinical potential and clinical implications of these drugs, concerning major cardiovascular priorities such as acute coronary syndromes, myocardial infarction, PTCA, cardiac surgery and transplantation.
References 1.    Fliegel L., Frohlrch O.: The Na+/H+ exchanger: An update on structure, regulation and cardiac physiology. Bio- chem. J. 296 273-285 (1993)

2.    Mahnensmith R.L., Aronson P.S.: The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes. Circ. Res. 56: 773-788 (1985)

3.    Scholz W., Albus U.: Potential of selective sodium-hydrogen exchange inhibitors in cardiovascular therapy. Card. Res. 29: 184-188

4.    Yano K., Maruyama T., Makino N., Matsui H., Yanaga T.: Effects of amiloride on the mechanical, electrical and biochemical aspects of ischemia-reperfusion injury. Mol. Cell Biochem. 121: 75-83(1993)

5.    Conti C.R.: New concept for treatment of acute myocardial ischaemia. Clin. Cardiol. 21: 234 (1998)

6.    Flameng W.: New strategies for intraoperative myocardial protection. Cur. Opin. Cardiol. 19: 577-583 (1995)

7.    Erdhardt L.R.: GUARD During Ischemia Against Necrosis (GUARDIAN) Trial in acute coronary syndromes. Am. J. Cardiol. 83: 236-256 (1999)

8.    Counillon L., Pouyssegur J.: Structure, function and regulation of vertebrate Na+/H+ exchangers (NHE). Curr. Opin. Nephrol. Hyperlens. 2: 708-714 (1993)

9.    Counillon L., Pouyssegur J.: Structure-function studies and molecular regulation of the growth factor activatable sodium-hydrogen exchanger (NHE-1). Card. Res. 29: 147- 154 (1995)

10.  Lucchesi P.A., Berk B.C.: Regulation of sodium-hydrogen exchange in vascular smooth muscle. Card. Res. 29: 172-177 (1995)

11.  Puceat M., Vassort G.: Neurohumoral modulation of intracellular pH in the heart. Card. Res. 29: 178-183 (1995)

12.  Barber D.L.: Mechanisms of receptor-mediated regulation of Na-H exchange. Cell. Signallings. 387-397 (1991)

13.  Wallert M.A., Frohlich O.: at-Adrenergic stimulation of Na-H exchange in cardiac myocytes. Am. J. Physiol. 263: C1096-1102 (1992)

14.  Lazdunski M., Frelin C., Vigne P.: The sodium-hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J. Mol. Cell Cargdiol. 17: 1029-1042(1985)

15.  Frelin C., Vigne P., Lazdunski M.: The role of Na+/H+ exchange system in cardiac cells in relation to the control of the internal Na+ concentration. J. Biol. Chem. 259. 8880-8885 (1984)

16.  Scholz W., Albus U., Linz W., et al.: Effects of Na+/H+ exchange inhibitors in cardiac ischaemia. J. Mol. Cell Cardiol. 24: 731-739 (1992)

17.  Pierce G.N., Meng H.: The role of sodium-proton exchange in ischemic-reperfusion injury in the heart. Am. J. Cardiovasc. Pathol. 4: 91-102 (1992)

18.  Karmazyn M.: Ischemic and reperfusion injury in the heart. Cellular mechanisms and pharmacological interventions. Can. J. Physiol. Pharmacol. 69: 719-730 (1990)

19.  Miura Y., Kimura J.: Sodium-calcium exchange current. Dependence on internal Ca+ and Na+ and competitive binding of external Na+ and Ca+. J. Gen. Physiol. 92: 1129- 1145 (1989)

20.  Kimura J., Noma A., Irisawa H.: Na-Ca exchange current in mammalian heart cells. Nature 312: 596-597 (1986)

21.  Tani M., Neely J.R.: Role of intracellular Na+ in Ca+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Circ. Res. 65: 1045-1056 (1989)

22.  Steenbergen C., Murphy E., Watts J.A., London R.E.: Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ. Res. 66: 135-146 (1990)

23.  Shen A.C., Jennings R.B.: Kinetics of calcium accumulation in acute myocardial ischemic injury. Am. J. Pathol. 67: 441-452 (1972)

24.  Tonnessen T.I., Sandvig K., Olsnes S.: Role of Na+ /H+ and CI/HCO3 antiports in the regulation of cytosolic pH near neutrality. Am. J. Physiol. 252: C1117-1126 (1990)

25.  Vandenberg J.I., Metcalfe J.C., Grace A.A.: Mechanisms of pH recovery after global ischemia in the perfused heart. Circ. Res. 72: 993-1003 (1993)

26.  Murphy E., Perlman M., London R.E., Steenbergen C.: Amiloride delays the ischemia induced rise in cytosolic free calcium. Circ. Res. 68: 1250-1258 (1991)

27.  Karmazyn M.: Amiioride enhances postischemic ventricular recovery: possible role of Na/H exchange. Am. J. Physiol. 255: H608-615 (1988)

28.  Meng H.P., Maddaford T.G., Pierce G.N.: Effect of amiloride and selected analogues on postischemic recovery of cardiac contractile function. Am. J. Physiol. 264: H1831-1835 (1993)

29.  Pierce G.N., Cole W.C., Liu K., et al.: Modulation of cardiac performance by amiloride and several selected derivatives of amiloride. J. Pharmacol. Exp. Ther. 265: 1280-1291 (1993)

30.  Moffat M.P., Karmazyn M.: Protective effects of the potent Na/H exchange inhibitor methylisobutyl amiloride against post-ischaemic contractile dysfunction in rat and guinea-pig hearts. J. Mol. Cell Cardiol. 265: 959-971 (1993)

31.  Scholz W., Albus U., Lang H.J., et al.: HOE 694, a new Na+ /H+ exchange inhibitor, and its effects in cardiac ischaemia. Br. J. Pharmacol. 102: 562-568 (1993)

32.  Myers M.L, Mathur S., Li G.H., Karmazyn M.: Sodium-hydrogen exchange inhibitors improve postischaemic recovery of function in the perfused rabbit heart. Card. Res. 22: 209-214 (1995)

33.  Meng H.P., Lonsberry B.B., Pierce G.N.: Influence of perfusate pH on the postischaemic recovery of cardiac contractile function: involvement of sodium-hydrogen exchange. J. Pharmacol. Exp. Ther. 252: 772-777 (1991)

34.  Sack S., Mohr M., Schwarz E.R., et al.: Effects of a new Na+ /H+ antiporter inhibitor on postischemic reperfusion in pig heart. J. Cardiovasc. Pharmacol. 23: 72-78 (1994)

35.  Opie L.H.: Reperfusion injury and its pharmacologic modification. Circulation 80: 1049-1062 (1989)

36.  Duff H.J., Mitchell L.B., et al.: Antiarrhythmic and electrophysiologic actions in patients with inducible sub-stained ventricular tachycardia. Circulation 79: 1257-1263 (1989)

37.  Stringham J.C., Sorthard J.H., et al.: Limitation of heart preservation by cold storage. Transplantation 53: 287-294 (1992)

38.  Bugge E., Ytrehus K.: Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart – a protective additive to ischaemic preconditioning. Card. Res. 29: 269-274 (1995)

39.  Bugge E., Munch-Etlingsen J., Ytrehus K.: Reduced infarct size in the rabbit heart in vivo by ethytisopropylamiloride. A role for Na+/H+ exchange. Bas. Res. Cardiol. 91: 203-209 (1996)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2001 – ANNUAL SUBSCRIPTION 2001
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

Bookmark the permalink.

Comments are closed.